Shanghai Zhaxin Hospital/Shanghai Liquan Hospital, GoBroad Medical Institute of Hematology (Shanghai Center) stands as a comprehensive healthcare facility with a specialized focus on the diagnosis and treatment of hematological disorders. Recognized as an integral member of the Shanghai Ruijin Hospital Blood Disease Medical Association, it operates under the distinction of being a designated hospital for Shanghai’s medical insurance scheme. Zhaxin Hospital further extends its accessibility by offering real-time settlement services for national cross-regional medical insurance claims, as well as direct payment services for commercial health insurance policies. Adding to its credentials, it holds the esteemed designation as a certified center for bone marrow transplantation in China. Together, they boast over 300 beds, including 32 specialized laminar airflow rooms for hematopoietic stem cell transplantation. The hospital features departments for medical laboratory services, blood banks, medical imaging, pharmacy, and more. In addition to routine clinical laboratory tests, they are equipped to conduct specialized laboratory examinations pertinent to hematological diagnosis and treatment, such as cellular morphology analysis, flow cytometry, chromosome assessment, fluorescence in situ hybridization (FISH), genetic testing, and polymerase chain reaction (PCR) testing.

Our hospital adopts "The Needs of the Patient Come First" as its core philosophy, starting with patients' needs and committed to their satisfaction. We have strong expertise in the treatment of hematologic disorders, including the diagnosis and treatment of multiple myeloma, relapse leukemia, and others. These treatments are predominantly adoptive cellular immunotherapy, involving CAR T transplant, HSCT treatment (or BMT treatment), etc. Cell immunotherapy, such as CAR T treatment for lymphoma and leukemia, is a highly promising cutting-edge technology for blood diseases and is preferred by many patients. We also have a pioneering integrative diagnostic system and a multidisciplinary health team, which allows us to provide more customized healthcare services to our patients.

GoBroad Medical Institute of Hematology (Shanghai Center)  is led by Professor Wang Chun, former director of the Hematology Department at Shanghai General Hospital. With over 30 years of profound experience in the field of hematological disease treatment, Professor Wang is particularly renowned for his expertise in hematopoietic stem cell transplantation for refractory leukemia, with a special emphasis on elderly patients, as well as anti-infection strategies in hematology, earning him high accolades and recognition both nationally and internationally within the academic community. The core team of medical professionals, nurses, and technicians hail from Shanghai General Hospital, bringing with them rich practical experience in diagnosing, treating, and caring for various types of hematological disorders. This collective expertise has shaped the center's specialized features, encompassing:

● Precision Diagnosis and Treatment of Malignant Hematological Diseases
● Elderly Leukemia
● Salvage Therapy for Refractory Leukemia
● T Cell Lymphoma
● Salvage Therapy for Relapsed/Refractory Lymphoma
● Immunosuppressive Therapy for Severe Aplastic Anemia
● Treatment of Primary Myelofibrosis
● Salvage Therapy for Myelodysplastic Syndromes
● Personalized Immunotherapy Post-Allogeneic Hematopoietic Stem Cell Transplantation
● Dual Transplantation Strategy (Autologous Followed by Allogeneic) for Multiple Myeloma